Youth with bipolar spectrum disorders (BSD) are frequently prescribed second-generation antipsychotics (SGAs). Nonadherence to treatment often results in increased mood symptoms and diminished quality of life. We examined SGA adherence rates and adherence barriers among youth who have overweight/obesity and are diagnosed with BSD enrolled in a multisite pragmatic clinical trial.
No takes yet. Share an insight, caveat, or question.
Klein et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: